Evaluate w H P including contributing meds risk factors and perform stone analysis urine blood biochemistry in all first time stone formers for potential treatable metabolic d o tailored tx 1 2 Ca stones are most common type 3 Perform detailed eval in hig

Evaluate w/ H&P including contributing meds & risk factors and perform stone analysis ± urine/blood biochemistry in all first-time stone formers for potential, treatable metabolic d/o & tailored tx.^1,2 Ca++ stones are most common type.³ Perform detailed eval in high risk/recurrent stone-formers only [B] per AUA.1 ACP says evidence insufficient that stone composition and blood/urine monitoring reduce recurrence³